Investor
The California-based company will use the funds to acquire regulatory clearance for its miLens offering.
The company will develop experiences that train individuals in the biopharmaceutical and life sciences sectors.
Initially filed in 2022, the complaint alleged the company's representatives misled investors following its $18.5 billion acquisition of Livongo.
Ralf-Gordon Jahns, managing director of Research2Guidance, joins MobiHealthNews to discuss R2G's findings on effective monetization strategies for digital health solutions.
The app is increasingly becoming popular among Indonesian mothers.
Lynne Chou O'Keefe, founder and managing partner of Define Ventures, tells MobiHealthNews what characteristics of a company are essential to garner investment.
The hybrid platform offers Medicare Advantage recipients behavioral health services. It will use the funds to grow its partnerships with insurance providers.
The funding comes three months after the company announced it added AI-enabled imaging features and new indications expanding xvision's use to the whole spine.
The company will use the funds to release new offerings to providers and payers, expand its reach nationally in 2023 and establish a presence in all 50 states in 2024.
HIMSS23
Hal Wolf, HIMSS president and CEO, discusses the organization's announcement of establishing its international headquarters in Rotterdam and how it impacts HIMSS' chapters and partnerships working to advance digital transformation globally.